跳至主要内容
临床试验/NCT00540150
NCT00540150已完成3 期

Compatibility and Immunogenicity of a Short Specific Immunotherapy (SIT) in Contrast to Classic Specific Immunotherapy in a Randomized Study Depending on Mite-Depot Supplement in Children and Adolescents With Allergic Bronchial Asthma.

Johann Wolfgang Goethe University Hospital2 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2004年5月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
34
试验地点
2
主要终点
Safety of the shortened specific immunotherapy.

研究概览

简要总结

We wanted to examine the immunogenicity and safety of a shortened specific immunotherapy in contrast to the standard specific immunotherapy.

Therefore, we challenged 12 patients for 14 weeks with the standard specific scheme and 22 patients for 6 weeks with the shortened scheme.

详细描述

see above

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
6 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • informed consent of patient and/or parents
  • age >6 and <18 years
  • bronchial asthma I° or II°
  • allergy on house dust-mite

排除标准

  • age <6 and >18 years
  • vital capacity <80% or FEV1 <70%
  • pregnancy
  • inhalative or systemic steroid use
  • bronchial asthma III° or IV°
  • heavy exacerbation during the last 3 months

结局指标

主要结局

Safety of the shortened specific immunotherapy.

时间窗: may 2004 - march 2005

次要结局

  • Exhaled nitric oxid (eNO) and immunogenicity (IgE, specific IgE, specific IgG) in both groups.(may 2004 - march 2005)

研究者

发起方
Johann Wolfgang Goethe University Hospital
申办方类型
Other

研究点 (2)

Loading locations...

相似试验